Pricing Log in Create free account

Fortrea Holdings Inc. (FTRE) vs Replimune Group, Inc. (REPL)

Fortrea Holdings Inc. and Replimune Group, Inc. are both Biotechnology companies. Fortrea Holdings Inc. and Replimune Group, Inc. are of similar size ($2.0B and $1.9B). Replimune Group, Inc. has the higher net margin (0.00% vs −2.58%) and the lower return on invested capital (−928.3% vs 0.59%). Across the 14 metrics below, Fortrea Holdings Inc. leads on 9 and Replimune Group, Inc. on 5.

Valuation

Metric FTRE REPL Biotechnology median
P/E n/m n/m 10.60
P/S 0.79 n/m 9.40
P/B 3.94 11.16 2.13
Price to free cash flow 12.27 n/m 25.18
EV/EBITDA 32.06 n/m 0.66
EV/Sales 1.10 n/m 9.02
Earnings yield (3.34%) (12.86%) (32.88%)
Free cash flow yield 8.15% (10.75%) (23.13%)

Profitability

Metric FTRE REPL Biotechnology median
Gross margin 20.00% 0.00% 68.51%
Operating margin 0.48% 0.00% 0.00%
Net margin (2.58%) 0.00% 0.00%
Free cash flow margin 6.41% 0.00% 0.00%
Return on equity (12.34%) (115.80%) (51.96%)
Return on assets (2.51%) (71.01%) (46.06%)
Return on invested capital 0.59% (928.27%) 0.00%

Growth

Metric FTRE REPL Biotechnology median
Revenue growth (TTM) (3.38%) — 6.76%
EPS growth (last fiscal year) (194.55%) (10.10%) 29.88%
Revenue growth, 5-year CAGR 1.09% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FTRE REPL Biotechnology median
Debt to equity 1.98 0.59 0.00
Current ratio 0.97 7.11 4.97
Net debt to EBITDA 266.13 0.51 1.01

Dividend

Metric FTRE REPL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric FTRE REPL Biotechnology median
Market cap 1.97b 1.90b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack